Ascend Clinical competitors

Dr. Ellison has served as our President and Chief Executive Officer since April 2020 and as a Director on our Board since January 2020. Dr. Ellison’s broad experience and leadership positions include Chief Executive Officer of the privately held biotechnology company, Promedior, Inc. (acquired by Roche); President and Chief Executive Officer of Bond Biosciences, Inc., a biotech start-up developing a drug addressing the toxic impact of iron overload in the body; Executive Director of Torreya Advisors, LLC, a life sciences investment banking firm; Chairman and Chief Executive Officer of Assembly Biosciences, Inc. (formerly Ventrus Biosciences, Inc.); Executive Vice President of Paramount Biosciences LLC, a global drug development and healthcare investment firm; Vice President of Clinical Development of FibroGen, Inc., where he played a key role in the early phase development of roxadustat in anemia for chronic kidney disease (CKD) patients; Vice President of Medical Affairs and Chief Medical Officer of Sanofi-Synthelabo US, Inc.; and Vice President, Medical Affairs and Chief Medical Officer of Hoffman La Roche, Inc. in the United States. Dr. Ellison previously served as an Independent Board Director for several private and public companies, including Cougar Biotechnology Inc.; ProSanos Corporation; Cormedix Inc., a cardio-renal clinical stage company; and Mt. Cook, a urology-focused company. Dr. Ellison received a Master of Science degree from the London School of Tropical Medicine and Hygiene, and an M.D. from the University of British Columbia.

Erhardt Preitauer is a Board Member at DAYTON DEVELOPMENT COALITION and President/CEO at CareSource. He has worked as Senior VP:Govt Programs at HORIZON BLUE CROSS BLUE SHIELD, Chief Executive Officer at Horizon NJ Health, and Regional VP:Aetna Medicaid at Aetna. Erhardt studied at Penn State University and Western Nevada College.

Michael Genord is a President/CEO at Health Alliance Plan and is based in Rochester, Michigan. He has experience at WILLIAM BEAUMONT HOSPITAL and has worked as Member, President's Council at Beaumont Health; Co-Chair, Clinical Integration Quality Committee at Beaumont United Care Partners; and Physician, Founder/Managing Partner at Women First Ob Gyn. Michael works or has worked as BOARD MEMBER at Health Plan Alliance, BOARD MEMBER at Greater Flint Health Coalition Inc, and BOARD MEMBER at Notre Dame Preparatory School. He attended Eli Broad Graduate School of Management, Michigan State University College of Human Medicine between 1989 and 1993, and Michigan State University - Eli Broad College of Business between 2011 and 2013.

Chief Operating Officer of Northern California-based Sutter Health, a not-for-profit health system caring for nearly 3 million patients-or one in every 100 Americans. Oversees operations across Sutter Health’s 24 hospitals and 5 medical foundations. Also deeply committed to working with the community to help solve some of our most challenging issues. I’m energized and grateful for the opportunity to help lead businesses, private philanthropists and elected officials in three counties to adopt a common housing-first framework with the goal of reaching functional zero for homelessness. I am on the Board of the CaIifornia Business Roundtable and the Greater Sacramento Area Economic Council. A strong, vibrant community with sufficient employment and advancement opportunities allows people to live more fulfilling, healthier lives.

Mr. Raymond Grahe A. is a Chief Executive Officer at Trivergent Health Alliance Mso, LLC and is based in United States.

As President and CEO of OCHIN, Abby Sears leads the nation's largest health information technology and innovation organization focused on the needs of primary care providers serving historically underserved communities nationwide. A prominent national speaker and HIT advisor, Abby is driven by the goal of health equity as she builds a premier information and technology network. Abby is steering OCHIN to harness the power of its membership, research, and data to change health outcomes through OCHIN's national reach.